Catalyst Wire Dossier Catalyst Wire Dossier

Acetaminophen/Naproxen Sodium

acetaminophen; naproxen sodium (combination) · Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Acetaminophen/Naproxen Sodium, covering 2024-04-11 to 2024-04-11. Get the full timeline:

Most recent: Clinical Trial Update: Acetaminophen/Naproxen Sodium Dose Ranging Study [Phase 2]

See pricing